CellSource Co., Ltd.
4880・Standard Market・Pharmaceuticals
Governance
Company with an Audit and Supervisory Committee (transitioned in January 2023). As of the filing date, the Board of Directors consists of 5 members (including 2 outside directors). A Nomination and Compensation Advisory Committee has been established, and separation of oversight and execution is pursued through the executive officer system, Management Committee, and Compliance/Risk Council.
Risk Management
Based on the Risk Management Regulations, the Compliance and Risk Council (headed by the President, with the company's retained attorney participating as an observer) evaluates risks using a matrix of "materiality" x "frequency of occurrence," formulates countermeasures, and conducts monitoring on a monthly basis. Climate change risks (physical, transition, and legal) are identified and managed using the TCFD framework, with a system in place for oversight by the Board of Directors.
Shareholder Returns
The basic policy is continuous and stable dividends based on a target payout ratio of 10%. For FY2026 (ending October 2026), the year-end dividend is forecast at ¥0.00 (annual dividend of ¥0.00) as the full-year earnings forecast anticipates an operating loss. The previous fiscal year's actual year-end dividend was ¥5.00 per share (total dividends of ¥99,096 thousand).
Dividend Policy
The basic policy is to pay continuous and stable dividends based on a target payout ratio of 10%. Dividends of surplus are generally planned as a single year-end dividend per year (an interim dividend is also permitted under the articles of incorporation). For FY2025 (ended October 2025), the actual year-end dividend was ¥5.00 per share (annual dividend of ¥5.00). For FY2026 (ending October 2026), the second-quarter-end dividend is ¥0.00 and the forecast year-end dividend is ¥0.00 (annual dividend of ¥0.00). This is due to the full-year earnings forecast anticipating an operating loss and net loss.
ESG
The company promotes HSF management focused on Human, Social, and Future, positioning the resolution of aging population, declining birthrate, and fiscal challenges as its social mission. It conducts climate change risk and opportunity analysis based on the TCFD framework, with a renewable energy ratio of 8.25% for FY2025 (ending October 2025). While it aims for carbon neutrality by 2050, specific indicators and numerical targets have not yet been set. Regarding human capital, it discloses a female ratio of 23.8% among management positions, but has not set specific target ratios for women or foreign nationals.
Last updated: January 28, 2026